Paradoxical Association Between Dietary Lifestyle and Cardiovascular Risk: Cross-Sectional Analysis of Patient Responses from A Tertiary Care Hospital
Pharmaceutical Science-Pharmacy practice
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.5.P205-214Keywords:
Cardiovascular, Hypercholesterolemia, Refined Food, Ultra Processed, AtherosclerosisAbstract
A decrease in cardiovascular event risk with a decrease in total and LDL – cholesterol level is termed as “cholesterol paradox” or “risk factor reversal”. Cardiovascular risk does not have a linear relationship between LDL – cholesterol levels, and other substantial risk factors of cardiovascular events are being disregarded. The aim of this study is, to identify modifiable risk factors of cardiovascular events other than those well proved to cause dyslipidemia. A cross-sectional study was conducted with 652 participants in a tertiary care hospital. Patients were grouped into two, based on the history of cardiovascular events. Demographics and patient responses captured using pre-validated questionnaires were analyzed. 5mL blood samples were collected by venipuncture and lipid profile was estimated. Association between cardiovascular events and explanatory variables. was determined using Chi square test and Odds ratio at 95% confidence intervals. Higher risk of CV events was found among smokers 0.232 [0.144 – 0.373]. Consumption of white sugar, refined oil, processed cold beverages and fast food products increased CV risk respectively. Moreover, total cholesterol, LDL-C and triglycerides were found to decrease after one year of counselling the patients. The classical hypothesis of dyslipidemia induced atherosclerosis may not be the predominant cause of CV events. Herein, we report no association between high fat diet and CV risk while we observed higher risk in consumers of refined and ultra processed food products. However, significant control of cholesterol was observed in patients who shifted to Unrefined food products.
References
Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoğlu L, Lewis EF. Atherosclerosis. Nat Rev Dis Primers. 2019 Aug 16;5(1):56. Doi: 10.1038/S41572-019-0106-Z. PMID: 31420554.
Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology Of Coronary Heart Disease And Acute Coronary Syndrome. Ann Transl Med. 2016;4(13):256. Doi:10.21037/Atm.2016.06.3.
Ference BA, Ginsberg HN, Graham I, Et Al. Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. 1. Evidence From Genetic, Epidemiologic, And Clinical Studies. A Consensus Statement From The European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. Doi:10.1093/Eurheartj/Ehx144.
Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia And Atherosclerosis. Lipids Health Dis. 2017 Dec 6;16(1):233. Doi: 10.1186/S12944-017-0625-0.
Byrne P, Cullinan J, Smith A, Smith SM. Statins For The Primary Prevention Of Cardiovascular Disease: An Overview Of Systematic Reviews. BMJ Open. 2019;9(4):E023085. Published 2019 Apr 23. Doi:10.1136/Bmjopen-2018-023085.
Bae JM, Yang YJ, Li ZM, Ahn YO. Low Cholesterol Is Associated With Mortality From Cardiovascular Diseases: A Dynamic Cohort Study In Korean Adults. J Korean Med Sci. 2012;27(1):58-63. Doi:10.3346/Jkms.2012.27.1.58.
Nago N, Ishikawa S, Goto T, Kayaba K. Low Cholesterol Is Associated With Mortality From Stroke, Heart Disease, And Cancer: ThejichiMedical School Cohort Study. J Epidemiol. 2011;21(1):67-74. Doi:10.2188/Jea.Je20100065.
Simes RJ. Low Cholesterol And Risk Of Non-Coronary Mortality. Aust N Z J Med. 1994 Feb;24(1):113-9. Doi: 10.1111/J.1445-5994.1994.Tb04446.X.
Filippatos TD, Elisaf MS. EvacetrapibAnd Cardiovascular Outcomes: Reasons For Lack Of Efficacy. J Thorac Dis. 2017;9(8):2308-2310. Doi:10.21037/Jtd.2017.07.75.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McinnesGT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention Of Coronary And Stroke Events With Atorvastatin In Hypertensive Patients Who Have Average Or Lower-Than-Average Cholesterol Concentrations, In The Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial. Lancet. 2003 Apr 5; 361(9364):1149-58. Doi: 10.1016/S0140-6736(03)12948-0.
Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP. Efficacy AndSafety Of Adding Ezetimibe To Statin Therapy Among Women And Men: Insight From IMPROVE-IT (Improved Reduction Of Outcomes: Vytorin Efficacy International Trial). J Am Heart Assoc. 2017 Nov 18;6(11):E006901. Doi: 10.1161/JAHA.117.006901.
HPS2-THRIVE Collaborative Group. HPS2-THRIVE Randomized Placebo-Controlled Trial In 25 673 High-Risk Patients Of ER Niacin/Laropiprant: Trial Design, Pre-Specified Muscle And Liver Outcomes, And Reasons For Stopping Study Treatment. Eur Heart J. 2013 May;34(17):1279-91. Doi: 10.1093/Eurheartj/Eht055. Epub2013 Feb 26.
DubroffR. Cholesterol Paradox: A Correlate Does Not A Surrogate Make. Evid Based Med. 2017 Mar;22(1):15-19. Doi: 10.1136/Ebmed-2016-110602. Epub2016 Dec 20. PMID: 27998881.
Mach F, Ray KK, Wiklund O, Et Al. Adverse Effects Of Statin Therapy: Perception Vs. The Evidence - Focus On Glucose Homeostasis, Cognitive, Renal And Hepatic Function, Haemorrhagic Stroke And Cataract. Eur Heart J. 2018;39(27):2526-2539. Doi:10.1093/Eurheartj/Ehy182.
Tamanna N, Mahmood N. Food Processing AndMaillard Reaction Products: Effect On Human Health And Nutrition. Int J Food Sci. 2015;2015:526762. Doi:10.1155/2015/526762.
Srour B, Fezeu LK, Kesse-Guyot E, Et Al. Ultra-Processed Food Intake And Risk Of Cardiovascular Disease: Prospective Cohort Study (Nutrinet-Santé). BMJ. 2019;365:L1451. Published 2019 May 29. Doi:10.1136/Bmj.L1451.
Yu E, Malik VS, Hu FB. Cardiovascular Disease Prevention ByDiet Modification: JACC Health Promotion Series. J Am Collcardiol. 2018;72(8):914-926. Doi:10.1016/J.Jacc.2018.02.085.
Cawthorn WP, Sethi JK. TNF-Alpha And Adipocyte Biology. FEBS Lett. 2008;582(1):117-131. Doi:10.1016/J.Febslet.2007.11.051.
Smith CS, Cannon CP, MccabeCH, Murphy SA, Bentley J, Braunwald E. Early Initiation Of Lipid-Lowering Therapy For Acute Coronary Syndromes Improves Compliance With Guideline Recommendations: Observations From The OrbofibanIn Patients With Unstable Coronary Syndromes (OPUS-TIMI 16) Trial. Am Heart J. 2005 Mar;149(3):444-50. Doi: 10.1016/J.Ahj.2004.06.033.
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanwagnerLB, Tsao CW; American Heart Association Council On Epidemiology And Prevention Statistics Committee And Stroke Statistics Subcommittee. Heart Disease AndStroke Statistics-2020 Update: A Report From The American Heart Association. Circulation. 2020 Mar 3;141(9):E139-E596. Doi: 10.1161/CIR.0000000000000757. Epub2020 Jan 29. PMID: 31992061.
Budzyński J, Tojek K, Wustrau B, Et Al. The "Cholesterol Paradox" Among Inpatients - Retrospective Analysis Of Medical Documentation. Arch Med SciatherosclerDis. 2018;3:E46-E57. Published 2018 Mar 27. Doi:10.5114/Amsad.2018.74736.
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: Process, Indicators, Risk Factors And New Hopes. Int J Prev Med. 2014;5(8):927-946.
Saeed A, Kampangkaew J, Nambi V. Prevention OfCardiovascular Disease In Women. Methodist DebakeycardiovascJ. 2017;13(4):185-192. Doi:10.14797/Mdcj-13-4-185.
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The Protective Role OfEstrogen And Estrogen Receptors In Cardiovascular Disease And The Controversial Use Of Estrogen Therapy. Biol Sex Differ. 2017;8(1):33. Published 2017 Oct 24. Doi:10.1186/S13293-017-0152-8.
Jabri A, Kumar A, Verghese E, Alameh A, Kumar A, Khan MS, Khan SU, Michos ED, Kapadia SR, Reed GW, Kalra A. Meta-Analysis Of Effect Of Vegetarian Diet On Ischemic Heart Disease And All-Cause Mortality. Am J Prevcardiol. 2021 Apr 9;7:100182. Doi: 10.1016/J.Ajpc.2021.100182.
Poursafa P, Moosazadeh M, Abedini E, Et Al. A Systematic Review On TheEffects Of Polycyclic Aromatic Hydrocarbons On Cardiometabolic Impairment. Int J Prev Med. 2017;8:19. Published 2017 Apr 6. Doi:10.4103/Ijpvm.IJPVM_144_17.
Manchanda SC, Passi SJ. Selecting Healthy Edible Oil In The Indian Context. Indian Heart J. 2016;68(4):447-449. Doi:10.1016/J.Ihj.2016.05.004.
Srour B, Fezeu LK, Kesse-Guyot E, Allès B, Méjean C, Andrianasolo RM, Chazelas E, Deschasaux M, Hercberg S, Galan P, Monteiro CA, Julia C, Touvier M. Ultra-Processed Food Intake And Risk Of Cardiovascular Disease: Prospective Cohort Study (Nutrinet-Santé). BMJ. 2019 May 29;365:L1451. Doi: 10.1136/Bmj.L1451.
Pacheco LS, Lacey JV Jr, Martinez ME, Lemus H, Araneta MRG, Sears DD, Talavera GA, Anderson CAM. Sugar-Sweetened Beverage Intake AndCardiovascular Disease Risk In The California Teachers Study. J Am Heart Assoc. 2020 May 18;9(10):E014883. Doi: 10.1161/JAHA.119.014883. Epub2020 May 13. PMID: 32397792; PMCID: PMC7660873.
Al-Shaar L, Satija A, Wang DD, Rimm EB, Smith-Warner SA, Stampfer MJ, Hu FB, Willett WC. Red Meat Intake And Risk Of Coronary Heart Disease Among US Men: Prospective Cohort Study. BMJ. 2020 Dec 2;371:M4141. Doi: 10.1136/Bmj.M4141. PMID: 33268459; PMCID: PMC8030119.
Zhang B, Xiong K, Cai J, Ma A. Fish Consumption AndCoronary Heart Disease: A Meta-Analysis. Nutrients. 2020 Jul 29;12(8):2278. Doi: 10.3390/Nu12082278. PMID: 32751304; PMCID: PMC7468748.
London B., Albert C., Anderson M.E., Giles W.R., Van Wagoner D.R., Balk E., Billman G.E., Chung M., Lands W., Leaf A., Et Al. Omega-3 Fatty Acids And Cardiac Arrhythmias: Prior Studies And Recommendations For Future Research: A Report From The National Heart, Lung, And Blood Institute And Office Of Dietary Supplements Omega-3 Fatty Acids And Their Role In Cardiac Arrhythmogenesis Workshop. Circulation. 2007;116:E320–E335.
Aune D, GiovannucciE,Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S. Fruit And Vegetable Intake And The Risk Of Cardiovascular Disease, Total Cancer And All-Cause Mortality-A Systematic Review And Dose-Response Meta-Analysis Of Prospective Studies. Int J Epidemiol. 2017 Jun 1;46(3):1029-1056. Doi: 10.1093/Ije/Dyw319. PMID: 28338764; PMCID: PMC5837313.
Kopčeková, J., Holovičová, M., Gažarová, M., Mrázová, J., Habánová, M., Mečiarová, L., &Bronkowska, M. (2020). Association Between Selected Dietary Habits AndLipid Profiles Of Patients With Cardiovascular Disease. International Journal Of Environmental Research And Public Health, 17(20), 7605. Https://Doi.Org/10.3390/Ijerph17207605.
Popkin BM, Adair LS, Ng SW. Global Nutrition Transition And The Pandemic Of Obesity In Developing Countries. Nutr Rev. 2012;70:3–21.
Bhupathiraju SN, Tobias DK, Malik VS, Et Al. GlycemicIndex, Glycemic Load, And Risk Of Type 2 Diabetes: Results From 3 Large US Cohorts And An Updated Meta-Analysis. Am J Clinnutr. 2014;100:218–232.
R. S. VenkateshAndZahedaBano. A Survey On Risk Assessment Among Populations After Following Keto Diet. Int J Pharm Bio Sci. 2019; 9(4): 41-43.
Mirrahimi A, De Souza RJ, Chiavaroli L, Et Al. Associations OfGlycemic Index And Load With Coronary Heart Disease Events: A Systematic Review And Meta-Analysis Of Prospective Cohorts. J Am Heart Assoc. 2012;1:E000752.
Mensink RP, Zock PL, Kester AD, Katan MB. Effects Of Dietary Fatty Acids And Carbohydrates On The Ratio Of Serum Total To HDL Cholesterol And On Serum Lipids And Apolipoproteins: A Meta-Analysis Of 60 Controlled Trials. Am J Clinnutr. 2003;77:1146–55.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Sumathy T, Maheshkumar V .P, Jaikumar S
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
